Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Parikh Aparna R et al. Nature medicine 2019 Sep (9) 1415-1421

Main|Search|PHGKB




Last Posted: Sep 11, 2019

---

• Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
  Parikh Aparna R et al. Nature medicine 2019 Sep (9) 1415-1421
• Applications of liquid biopsies for cancer
  A Mattox et al. Sci Trans Med, August 28, 2019
• Detecting Circulating Tumor Cells Through the Skin
  J Abbasi, JAMA, August 2019
• Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics
  Z Li et al, Nature Comms, August 26, 2019
• Closing the 'phenotype gap' in precision medicine: improving what we measure to understand complex disease mechanisms.
  MacRae Calum A et al. Mammalian genome : official journal of the International Mammalian Genome Society 2019 Aug
• Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers.
  Jacobson Richard A et al. Cancers 2019 Aug 11(8)
• Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine.
  Luchini Claudio et al. Cancers 2019 Aug 11(8)
• Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool.
  Kunnath Anil P et al. Cureus 2019 Jun 11(6) e4907
• Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
  Del Re Marzia et al. International journal of molecular sciences 2019 Aug 20(16)
• Circulating microbiota-derived metabolites: a "liquid biopsy?
  Aragonès Gemma et al. International journal of obesity (2005) 2019 Aug

more